🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this platform study is to evaluate the safety, tolerability,...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2024-01-18
Trial ID
NCT06162221
Treatments Being Tested
This Expanded Access Program (EAP) is intended to provide daraxonrasib to e...
Status
Available
Location
Alabama Oncology
Start Date
TBD
Trial ID
NCT07573215
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of a novel...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2024-10-16
Trial ID
NCT06625320
The purpose of this platform study is to evaluate the safety, tolerability,...
Status
Recruiting
Location
Ironwood Cancer and Research Centers
Start Date
2024-05-24
Trial ID
NCT06445062
The purpose of this study is to evaluate the safety and efficacy of a novel...
Status
Recruiting
Location
Alabama Oncology
Start Date
2025-05-06
Trial ID
NCT06881784
Treatments Being Tested
This study is to evaluate the safety, tolerability, and PK profiles of Elir...
Status
Recruiting
Location
City of Hope
Start Date
2023-11-14
Trial ID
NCT06128551
Treatments Being Tested
This is an open-label, multicenter Phase 2 study evaluating BMS-986504 in p...
Status
Recruiting
Location
Local Institution - 0096
Start Date
2026-07-27
Trial ID
NCT07492680
Evaluate the safety and tolerability of RMC-6236 in adults with specific RA...
Status
Recruiting
Location
UC Irvine/Chao Family Comprehensive Cancer Center
Start Date
2022-05-31
Trial ID
NCT05379985
Treatments Being Tested
The study aims to determine maximum tolerated dose (MTD) or recommended com...
Status
Active Not Recruiting
Location
Comprehensive Blood and Cancer Center
Start Date
2024-05-29
Trial ID
NCT06360354
Treatments Being Tested
TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to deter...
Status
Recruiting
Location
Mayo Clinic Scottsdale
Start Date
2025-05-31
Trial ID
NCT06922591
Treatments Being Tested